Arterial wall-determined risk factors to vascular diseases: A nonhuman primate model

Cell Biochemistry and Biophysics

Volumn 40, Issue 3, 2004, Pages 371-388

  Wang, Xing Li ^a,c   Wang, Jian ^a,c   Shi, Qiang ^a   Carey, K Dee ^a,b   VandeBerg, John L ^a,b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Endothelial cells; Nonhuman primates; Vascular diseases; Vascular smooth muscle cells

Indexed keywords

PAPIO; PAPIO HAMADRYAS; PRIMATES;

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR;

ANIMAL; APOPTOSIS; ARTERY; ATHEROSCLEROSIS; DISEASE MODEL; HUMAN; MICROCIRCULATION; PAPIO; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; ARTERIES; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; PAPIO; RECEPTORS, CELL SURFACE; RISK FACTORS; VASCULAR DISEASES;

EID: 3943099025     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:40:3:371     Document Type: Review

References (180)

1. American Heart Association. Heart disease and stroke statistics - 2003 updates. American Heart Association, Dallas, Texas, 2002.
2. Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561.
3. Kuvin, J. T. and Karas, R. H. (2003) Clinical utility of endothelial function testing: ready for prime time? Circulation 107, 3243-3247.
4. Badimon, J. J., Fuster, V., Chesebro, J. H., and Badimon, L. (1993) Coronary atherosclerosis. A multifactorial disease. Circulation 87, II3-II16.
5. Stary, H. C. (1989) Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9, I19-32.
6. Quyyumi, A. A. (1998) Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am. J. Med. 105, 32S-39S.
7. Dzau, V. J. (1994) PathoBiol.ogy of atherosclerosis and plaque complications. Am. Heart J. 128, 1300-1304.
8. Mombouli, J. V. and Vanhoutte, P. M. (1999) Endothelial dysfunction: from physiology to therapy. J. Mol. Cell. Cardiol. 31, 61-74.
9. Drexler, H. and Hornig, B. (1999) Endothelial dysfunction in human disease. J. Mol. Cell Cardiol.. 31, 51-60.
10. Schwartz, C. J., Valente, A. J., and Sprague, E. A. (1993) A modern view of atherogenesis. Am. J. Cardiol.. 71, 9B-14B.
11. Glagov, S., Zarins, C., Giddens, D. P., and Ku, D. N. (1988) Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch. Pathol. Lab. Med. 112, 1018-1031.
12. Straus, S. E., Majumdar, S. R., and McAlister, F. A. (2002) New evidence for stroke prevention: scientific review. JAMA 288, 1388-1395.
13. Benade, M. M. and Warlow, C. P. (2002) Costs and benefits of carotid endarterectomy and associated preoperative arterial imaging: a systematic review of health economic literature. Stroke 33, 629-638.
14. Mukherjee, D. and Yadav, J. S. (2000) Carotid and cerebrovascular disease. Cardiol. Rev 8, 322-332.
15. Tegos, T. J., Kalodiki, E., Daskalopoulou, S. S., and Nicolaides, A. N. (2000) Stroke: epidemiology, clinical picture, and risk factors - Part I of III. Angiology 51, 793-808.
16. Tegos, T. J., Kalodiki, E., Sabetai, M. M., and Nicolaides, A. N. (2000) Stroke: pathogenesis, investigations, and prognosis - Part II of III. Angiology 51, 885-894.
17. Wolf, P. A. and Grotta, J. C. (2000) Cerebrovascular disease. Circulation 102, IV75-IV80.
18. Strandness, D. E., Jr. (2000) Carotid artery disease: is the debate over? Vasc. Med. 5, 67-68.
19. Boccalon, H. (1999) Intermittent claudication in older patients. Practical treatment guidelines. Drugs Aging 14, 247-259.
20. van der Heijden-Spek, J. J., Staessen, J. A., Fagard, R. H., Hoeks, A. P., Boudier, H. A., and van Bortel, L. M. (2000) Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 35, 637-642.
21. Jost, S., Deckers, J. W., Nikutta, P., Rafflenbeul, W., Wiese, B., Hecker, H., et al. (1993) Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators. J. Am. Coll. Cardiol. 21, 1339-1346.
22. Kimura, B. J., Russo, R. J., Bhargava, V., McDaniel, M. B., Peterson, K. L., and DeMaria, A. N. (1996) Atheroma morphology and distribution in proximal left anterior descending coronary artery: in vivo observations. J. Am. Coll. Cardiol. 27, 825-831.
23. Ravensbergen, J., Ravensbergen, J. W., Krijger, J. K., Hillen, B., and Hoogstraten, H. W. (1998) Localizing role of hemodynamics in atherosclerosis in several human vertebrobasilar junction geometries. Arterioscler. Thromb. Vasc. Biol. 18, 708-716.
24. Shi, W., Wang, N. J., Shih, D. M., Sun, V. Z., Wang, X., and Lusis, A. J. (2000) Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ, Res, 86, 1078-1084.
25. Shi, W., Haberland, M. E., Jien, M. L., Shih, D. M., and Lusis, A. J. (2000) Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102, 75-81.
26. Hoeschen, R. J. (1997) Oxidative stress and cardiovascular disease. Can. J. Cardiol. 13, 1021-1025.
27. Dart, A. M. and Chin-Dusting, J. P. (1999) Lipids and the endothelium. Cardiovasc. Res. 43, 308-322.
28. Ruef, J., Peter, K., Nordt, T. K., Runge, M. S., Kubler, W., and Bode, C. (1999) Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb. Haemost. 82, 32-37.
29. Salvayre, R., Auge, N., Benoist, H., and Negre-Salvayre, A. (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta. 1585, 213-221.
30. Albertini, R., Moratti, R., and De Luca, G. (2002) Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr. Mol. Med. 2, 579-592.
31. Aviram, M. (2000) Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic. Res. 33, S85-S97.
32. Ursini, F., Zamburlini, A., Cazzolato, G., Maiorino, M., Bon, G. B., and Sevanian, A. (1998) Postprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis. Free Radic. Biol. Med. 25, 250-252.
33. Bruckdorfer, K. R. (1996) Antioxidants, lipoprotein oxidation, and arterial function. Lipids 31, S83-S85.
34. Naito, C., Kawamura, M., and Yamamoto, Y. (1993) Lipid peroxides as the initiating factor of atherosclerosis. Ann. NY Acad. Sci. 676, 27-45.
35. Hennig, B. and Chow, C. K. (1988) Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic. Biol. Med. 4, 99-106.
36. Musial, J., Domagala, T. B., and Szczeklik, A. (1992) Lipid peroxidation, vitamin E, and cardiovascular disease. J. Nutr. Sci. Vitaminol. (Tokyo), 200-203.
37. Warso, M. A. and Lands, W. E. (1983) Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br. Med. Bull. 39, 277-280.
38. Jain, S. K., Krueger, K. S., McVie, R., Jaramillo, J. J., Palmer, M., and Smith, T. (1998) Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients. Diabetes Care 21, 1511-1516.
39. Garcia-Valdecasas, J. C., Rull, R., Grande, L., Fuster, J., Rimola, A., Lacy, A. M., et al. (1995) Prostacyclin, thromboxane, and oxygen free radicals and postoperative liver function in human liver transplantation. Transplantation 60, 662-667.
40. Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., and Drexler, H. (2003) Role of oxidative stress in atherosclerosis. Am. J. Cardiol.. 91, 7A-11A.
41. Drexler, H. (1999) Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc. Res. 43, 572-579.
42. Sessa, W. C. (1994) The nitric oxide synthase family of proteins. J. Vasc. Res. 31, 131-143.
43. Shaul, P. W. (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol. 64, 749-774.
44. Morawietz, H., Talanow, R., Szibor, M., Rueckschloss, U., Schubert, A., Bartling, B., et al. (2000) Regulation of the endothelin system by shear stress in human endothelial cells. J. Physiol. 525, 761-770.
45. Malek, A. M., Greene, A. L., and Izumo, S. (1993) Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc. Natl. Acad. Sci. USA 90, 5999-6003.
46. Brown, M. R., Vaughan, J., Jimenez, L. L., Vale, W., and Baird, A. (1991) Transforming growth factor-beta: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology 129, 2355-2360.
47. Hexum, T. D., Hoeger, C., Rivier, J. E., Baird, A., and Brown, M. R. (1990) Characterization of endothelin secretion by vascular endothelial cells. Biochem. Biophys. Res. Commun. 167, 294-300.
48. Zucker, S., Mirza, H., Conner, C. E., Lorenz, A. F., Drews, M. H., Bahou, W. F., et al. (1998) Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int. J. Cancer 75, 780-786.
49. Savion, N., Gamliel, A., and Farzame, N. (1989) Anti-thrombin activity in cultured aortic and capillary endothelial cells: binding, internalization and degradation of thrombin. Eur. J. Cell. Biol. 49, 350-357.
50. Walsh, P. N. and Ahmad, S. S. (2002) Proteases in blood clotting. Essays Biochem. 38, 95-111.
51. Dahlback, B. (2000) Blood coagulation. Lancet 355, 1627-1632.
52. Esmon, C. T., Gu, J. M., Xu, J., Qu, D., Stearns-Kurosawa, D. J., and Kurosawa, S. (1999) Regulation and functions of the protein C anti-coagulant pathway. Haematologica 84, 363-368.
53. Nizzi, F. A., Jr. and Kaplan, H. S. (1999) Protein C and S deficiency. Semin. Thromb. Hemost. 25, 265-272.
54. Van Cott, E. M., Soderberg, B. L., and Laposata, M. (2002) Hypercoagulability test strategies in the protein C and protein S pathway. Clin. Lab. Med. 22, 391-403.
55. Vandenbroucke, J. P., Koster, T., Briet, E., Reitsma, P. H., Bertina, R. M., and Rosendaal, F. R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344, 1453-1457.
56. Bertina, R. M., Koeleman, B. P., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67.
57. Zoller, B., Svensson, P. J., He, X., and Dahlback, B. (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J. Clin. Invest. 94, 2521-2524.
58. Zoller, B. and Dahlback, B. (1994) Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343, 1536-1538.
59. Davis, G. E., Bayless, K. J., and Mavila, A. (2002) Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat. Rec. 268, 252-275.
60. Becker, B. F., Heindl, B., Kupatt, C., and Zahler, S. (2000) Endothelial function and hemostasis. Z. Kardiol. 89, 160-167.
61. Shen, G. X. (1998) Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (review). Int. J. Mol. Med. 1, 399-408.
62. Smith, E. B. (1996) Haemostatic factors and atherogenesis. Atherosclerosis 124, 137-143.
63. Nachman, R. L. and Hajjar, K. A. (1991) Endothelial cell fibrinolytic assembly. Ann. NY Acad. Sci. 614, 240-249.
64. Tripiciano, A., Palombi, F., Ziparo, E., and Filippini, A. (1997) Dual control of seminiferous tubule contractility mediated by ETA and ETB endothelin receptor subtypes. FASEB J. 11, 276-286.
65. Haywood, G. A., Gullestad, L., Katsuya, T., Hutchinson, H. G., Pratt, R. E., Horiuchi, M., et al. (1997) AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 95, 1201-1206.
66. McCaffrey, T. A., Consigli, S., Du, B., Falcone, D. J., Sanborn, T. A., Spokojny, A. M., et al. (1995) Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J. Clin. Invest. 96, 2667-275.
67. Cohn, J. N. (1999) Vascular wall function as a risk marker for cardiovascular disease. J. Hypertens. 17, S41-S44.
68. Smith, C. W. (1993) Leukocyte-endothelial cell interactions. Semin. Hematol. 30, 45-53; discussion 54-55.
69. Hubbard, A. K. and Rothlein, R. (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic. Biol. Med. 28, 1379-1386.
70. van de Stolpe, A. and van der Saag, P. T. (1996) Intercellular adhesion molecule-1. J. Mol. Med. 74, 13-33.
71. Dejana, E., Breviario, F., and Caveda, L. (1994) Leukocyte-endothelial cell adhesive receptors. Clin. Exp. Rheumatol. 12, S25-S28.
72. Libby, P. (2000) Changing concepts of atherogenesis. Herz 25, 108-112.
73. Libby, P., Geng, Y. J., Sukhova, G. K., Simon, D. I., and Lee, R. T. (1997) Molecular determinants of atherosclerotic plaque vulnerability. Ann. NY Acad. Sci. 811, 134-142; discussion 142-145.
74. Lincoff, A. M., Califf, R. M. and Topol, E. J. (2000) Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J. Am. Coll. Cardiol. 35, 1103-1115.
75. Fuster, V. and Griggs, T. R. (1986) Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis. Prog. Hemost. Thromb. 8, 159-183.
76. Badimon, L., Chesebro, J. H., and Badimon, J. J. (1992) Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 86, III74-III85.
77. Wu, K. K. (1997) Hemostatic tests in the prediction of atherothrombotic disease. Int. J. Clin. Lab. Res. 27, 145-152.
78. Kollros, P. R. and Konkle, B. A. (1997) Microvascular disease in diabetes mellitus. J. Cardiovasc. Risk 4, 70-75.
79. Cooper, M. E., Gilbert, R. E., and Jerums, G. (1997) Diabetic vascular complications. Clin. Exp. Pharmacol. Physiol. 24, 770-775.
80. Warpeha, K. M. and Chakravarthy, U. (2003) Molecular genetics of microvascular disease in diabetic retinopathy. Eye 17, 305-311.
81. Verrotti, A., Trotta, D., Salladini, C., Laura, M., and Chiarelli, F. (2003) Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control. Expert Opin. Pharmacother. 4, 525-532.
82. Yuan, S., Liu, Y., and Zhu, L. (1999) Vascular complications of diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 26, 977-978.
83. Dahl-Jorgensen, K. (1998) Diabetic microangiopathy. Acta. Paediatr. Suppl. 425, 31-34.
84. Johnson, R. J., Rodriguez-Iturbe, B., Schreiner, G. F., and Herrera-Acosta, J. (2002) Hypertension: a microvascular and tubulointerstitial disease. J. Hypertens. 20, S1-S7.
85. Imig, J. D. and Inscho, E. W. (2002) Adaptations of the renal microcirculation to hypertension. Microcirculation 9, 315-328.
86. Pries, A. R. and Secomb, T. W. (2002) Structural adaptation of microvascular networks and development of hypertension. Microcirculation 9, 305-314.
87. Boegehold, M. A. (2002) Microvascular structure and function in salt-sensitive hypertension. Microcirculation 9, 225-241.
88. Hayashi, K., Kanda, T., Homma, K., Tokuyama, H., Okubo, K., Takamatsu, I., et al. (2002) Altered renal microvascular response in Zucker obese rats. Metabolism 51, 1553-1561.
89. Agapitov, A. V., Correia, M. L., Sinkey, C. A., Dopp, J. M., and Haynes, W. G. (2002) Impaired skeletal muscle and skin microcirculatory function in human obesity. J. Hypertens. 20, 1401-1405.
90. Artwohl, M., Roden, M., Holzenbein, T., Freudenthaler, A., Waldhausl, W., and Baumgartner-Parzer, S. M. (2002) Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int. J. Obes. Relat. Metab. Disord. 26, 577-580.
91. Suhardja, A. and Hoffman, H. (2003) Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc. Res. Tech. 60, 70-75.
92. Weiss, L., Orr, F. W., and Honn, K. V. (1989) Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin. Exp. Metastasis 7, 127-167.
93. Christofferson, R. H., Skoldenberg, E. G., and Nilsson, B. O. (1997) Tumor growth in a defined microcirculation. Apmis 105, 487-496.
94. Matter, K. and Balda, M. S. (2003) Holey barrier: claudins and the regulation of brain endothelial permeability. J. Cell Biol. 161, 459-460.
95. Wolburg, H. and Lippoldt, A. (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc. Pharmacol. 38, 323-337.
96. Allaire, E., Muscatelli-Groux, B., Mandet, C., Guinault, A. M., Bruneval, P., Desgranges, P., et al. (2002) Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J. Vasc. Surg. 36, 1018-1026.
97. Lopez-Candales, A., Holmes, D. R., Liao, S., Scott, M. J., Wickline, S. A., and Thompson, R. W. (1997) Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am. J. Pathol. 150, 993-1007.
98. Jacob, T., Ascher, E., Hingorani, A., Gunduz, Y., and Kallakuri, S. (2001) Initial steps in the unifying theory of the pathogenesis of artery aneurysms. J. Surg. Res. 101, 37-43.
99. Bennett, M. R. and Boyle, J. J. (1998) Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138, 3-9.
100. Schwartz, S. M., Virmani, R., and Rosenfeld, M. E. (2000) The good smooth muscle cells in atherosclerosis. Curr. Atheroscler. Rep. 2, 422-429.
101. Bennett, M. R. (1999) Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 41, 361-368.
102. Scott, S., O'Sullivan, M., Hafizi, S., Shapiro, L. M., and Bennett, M. R. (2002) Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis. Circ. Res. 90, 398-404.
103. Mayr, M. and Xu, Q. (2001) Smooth muscle cell apoptosis in arteriosclerosis. Exp. Gerontol. 36, 969-987.
104. Andres, V. (1998) Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis (review). Int. J. Mol. Med. 2, 81-89.
105. Faxon, D. P., Coats, W., and Currier, J. (1997) Remodeling of the coronary artery after vascular injury. Prog. Cardiovasc. Dis. 40, 129-140.
106. Libby, P. and Tanaka, H. (1997) The molecular bases of restenosis. Prog. Cardiovasc. Dis. 40, 97-106.
107. Campbell, J. H., Campbell, G. R., Kocher, O., and Gabbiani, G. (1987) Cell biology of smooth muscle in culture: implications for atherogenesis. Int. Angiol. 6, 73-79.
108. Campbell, J. H. and Campbell, G. R. (1993) Culture techniques and their applications to studies of vascular smooth muscle. Clin. Sci. (Lond.) 85, 501-513.
109. Worth, N. F., Rolfe, B. E., Song, J., and Campbell, G. R. (2001) Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil. Cytoskeleton 49, 130-145.
110. Bennett, M. R. (2002) Apoptosis in the cardiovascular system. Heart 87, 480-487.
111. Best, P. J., Hasdai, D., Sangiorgi, G., Schwartz, R. S., Holmes, D. R., Jr., Simari, R. D., et al. (1999) Apoptosis: basic concepts and implications in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 19, 14-22.
112. Dimmeler, S., Hermann, C., and Zeiher, A. M. (1998) Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur. Cytokine Netw. 9, 697-698.
113. Bombeli, T., Karsan, A., Tait, J. F., and Harlan, J. M. (1997) Apoptotic vascular endothelial cells become procoagulant. Blood 89, 2429-2442.
114. Li, D., Yang, B., and Mehta, J. L. (1998) Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am. J. Physiol. 275, H568-H576.
115. Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., and Zeiher, A. M. (1997) Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res. 81, 970-976.
116. Stefanec, T. (2000) Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 117, 841-854.
117. Mutin, M., Canavy, I., Blann, A., Bory, M., Sampol, J., and Dignat-George, F. (1999) Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93, 2951-2958.
118. Dignat-George, F., Blann, A., and Sampol, J. (2000) Circulating endothelial cells in acute coronary syndromes. Blood 95, 728.
119. Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E., and Hebbel, R. P. (1997) Circulating activated endothelial cells in sickle cell anemia. New Engl. J. Med. 337, 1584-1590.
120. Dignat-George, F. and Sampol, J. (2000) Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur. J. Haematol. 65, 215-220.
121. Lin, Y., Weisdorf, D. J., Solovey, A., and Hebbel, R. P. (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105, 71-77.
122. Rafii, S. (2000) Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105, 17-19.
123. Dzau, V. J. and Horiuchi, M. (1998) Vascular remodeling - the emerging paradigm of programMed. cell death (apoptosis): the Francis B. Parker lectureship. Chest 114, 91S-99S.
124. Tanaka, K., Zou, J. P., Takeda, K., Ferrans, V. J., Sandford, G. R., Johnson, T. M., et al. (1999) Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 99, 1656-4659.
125. Schwartz, S. M., Majesky, M. W., and Murry, C. E. (1995) The intima: development and monoclonal responses to injury. Atherosclerosis 118, S125-S140.
126. Hasdai, D., Sangiorgi, G., Spagnoli, L. G., Simari, R. D., Holmes, D. R., Jr., Kwon, H. M., et al. (1999) Coronary artery apoptosis in experimental hypercholesterolemia. Atherosclerosis 142, 317-325.
127. Bennett, M. R., Evan, G. I., and Schwartz, S. M. (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95, 2266-2274.
128. Nishio, E., Arimura, S., and Watanabe, Y. (1996) Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 223, 413-418.
129. Haunstetter, A. and Izumo, S. (1998) Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82, 1111-1129.
130. Kockx, M. M. and Knaapen, M. W. (2000) The role of apoptosis in vascular disease. J. Pathol. 190, 267-280.
131. Newby, A. C. and Zaltsman, A. B. (1999) Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 41, 345-360.
132. Isner, J. M., Kearney, M., Bortman, S., and Passeri, J. (1995) Apoptosis in human atherosclerosis and restenosis. Circulation 91, 2703-2711.
133. Wever, R. M., Luscher, T. F., Cosentino, F., and Rabelink, T. J. (1998) Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97, 108-112.
134. Stary, H. C., Blankenhorn, D. H., Chandler, A. B., Glagov, S., Insull, W., Jr., Richardson, M., et al. (1992) A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. 12, 120-134.
135. Badimon, J. J., Ortiz, A. F., Meyer, B., Mailhac, A., Fallon, J. T., Falk, E., et al. (1998) Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. Atherosclerosis 140, 307-314.
136. Ballermann, B. J., Dardik, A., Eng, E., and Liu, A. (1998) Shear stress and the endothelium. Kidney Int. Suppl. 67, S100-S108.
137. Choi, K. S., Bae, M. K., Jeong, J. W., Moon, H. E., and Kim, K. W. (2003) Hypoxia-induced angiogenesis during carcinogenesis. J. Biochem Mol. Biol. 36, 120-127.
138. Harris, A. L. (2002) Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47.
139. Bobik, A., Agrotis, A., Kanellakis, P., Dilley, R., Krushinsky, A., Smirnov, V., et al. (1999) Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 99, 2883-2891.
140. Traystman, R. J. (2003) Animal models of focal and global cerebral ischemia. Ilar J. 44, 85-95.
141. Cramer, S. C. (2003) Clinical issues in animal models of stroke and rehabilitation. Ilar J. 44, 83-84.
142. Rekhter, M. (2002) Vulnerable atherosclerotic plaque: emerging challenge for animal models. Curr. Opin. Cardiol. 17, 626-632.
143. Karas, R. H. (2002) Animal models of the cardiovascular effects of exogenous hormones. Am. J. Cardiol. 90, 22F-25F.
144. Khalil, R. A. and Granger, J. P. (2002) Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R29-R45.
145. Rekhter, M. D. (2002) How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc. Res. 54, 36-41.
146. Wright, J. L. and Churg, A. (2002) A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 121, 188S-191S.
147. Daugherty, A. (2002) Mouse models of atherosclerosis. Am. J. Med. Sci. 323, 3-10.
148. Couffinhal, T., Dufourcq, P., Jaspard, B., Daret, D., Allieres, C., Alzieu, P., et al. (2001) Kinetics of adventitial repair in the rat carotid model. Coron. Artery Dis. 12, 635-648.
149. Jugdutt, B. I. (2002) The dog model of left ventricular remodeling after myocardial infarction. J. Card. Fail. 8, S472-S475.
150. Andaluz, N., Zuccarello, M., and Wagner, K. R. (2002) Experimental animal models of intracerebral hemorrhage. Neurosurg. Clin. N. Am. 13, 385-393.
151. Folts, J. D., Schafer, A. I., Loscalzo, J., Willerson, J. T., and Muller, J. E. (1999) A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J. Am. Coll. Cardiol. 33, 295-303.
152. Sakariassen, K. S., Hanson, S. R., and Cadroy, Y. (2001) Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy. Thromb. Res. 104, 149-174.
153. Stanley, W. C. (2000) In vivo models of myocardial metabolism during ischemia: application to drug discovery and evaluation. J. Pharmacol. Toxicol. Methods 43, 133-140.
154. Megyesi, J. F., Vollrath, B., Cook, D. A., and Findlay, J. M. (2000) In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46, 448-460.
155. Johnson, G. J., Griggs, T. R., and Badimon, L. (1999) The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb. Haemost. 81, 835-843.
156. Bocan, T. M. (1998) Animal models of atherosclerosis and interpretation of drug intervention studies. Curr. Pharm. Des. 4, 37-52.
157. Gross, D. R. (1997) Thromboembolic phenomena and the use of the pig as an appropriate animal model for research on cardiovascular devices. Int. J. Artif. Organs 20, 195-203.
158. Andre, P., Bal dit Sollier, C., Bonneau, M., Pignaud, G., Hainaud, P., Azzam, K., et al. (1996) Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics? Haemostasis 26, 55-69.
159. Wissler, R. W. and Vesselinovitch, D. (1990) Can atherosclerotic plaques regress? Anatomic and biochemical evidence from nonhuman animal models. Am. J. Cardiol. 65, 33F-40F.
160. Mahley, R. W. (1983) Development of accelerated atherosclerosis. Concepts derived from cell Biology and animal model studies. Arch. Pathol. Lab. Med. 107, 393-399.
161. Luginbuhl, H., Pauli, B., and Ratcliffe, H. L. (1974) Atherosclerosis in swine and swine as a model for the study of atherosclerosis. Adv. Cardiol. 13, 119-126.
162. McGill, H. C., Jr., Strong, J. P., Holman, R. L., and Werthessen, N. T. (1960) Arterial lesions in the Kenya baboon. Circulation Res. 8, 670-679.
163. McGill, H. C., Jr., Carey, K. D., McMahan, C. A., Marinez, Y. N., Cooper, T. E., Mott, G. E., et al. (1985) Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon. Arteriosclerosis 5, 481-493.
164. McGill, H. C., Jr. (1988) The pathogenesis of atherosclerosis. Clin. Chem. 34, B33-B39.
165. McGill, H. C., Jr., Mott, G. E., and Bramblett, C. A. (1976) Experimental atherosclerosis in the baboon. Primates Med. 9, 41-65.
166. Ruef, J., Hu, Z. Y., Yin, L. Y., Wu, Y., Hanson, S. R., Kelly, A. B., et al. (1997) Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ. Res. 81, 24-33.
167. Dichek, D. A., Anderson, J., Kelly, A. B., Hanson, S. R., and Harker, L. A. (1996) Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 93, 301-309.
168. Harker, L. A., Harlan, J. M., and Ross, R. (1983) Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ. Res. 53, 731-739.
169. McGill, H. C., Jr. and Sheridan, P. J. (1981) Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ. Res. 48, 238-244.
170. Holzknecht, Z. E., Kuypers, K. L., Plummer, T. B., Williams, J., Bustos, M., Gores, G. J., et al. (2002) Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ. Res. 91, 1135-1141.
171. Wada, H., Yamamuro, M., Inoue, A., Shiku, H., Sakuragawa, N., Redl, H., et al. (2001) Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis - toward a distinction between uncompensated overt DIC and compensated non-overt DIC. Thromb. Haemost. 86, 1489-1494.
172. Aavik, E., du Toit, D., Myburgh, E., Frosen, J., and Hayry, P. (2001) Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury. Mol. Cell. Endocrinol. 182, 91-98.
173. Du Toit, D., Aavik, E., Taskinen, E., Myburgh, E., Aaltola, E., Aimonen, M., et al. (2001) Structure of carotid artery in baboon and rat and differences in their response to endothelial denudation angioplasty. Ann. Med. 33, 63-78.
174. Noguchi, S., Kelly, A. B., Lumsden, A., Harker, L. A., and Wilcox, J. N. (1997) Identification of dysfunctional endothelial cells over vascular lesions in the non-human primate. Ann. NY Acad. Sci. 811, 506-514.
175. Rogers, J., Mahaney, M. C., Witte, S. M., Nair, S., Newman, D., Wedel, S., et al. (2000) A genetic linkage map of the baboon (Papio hamadryas) genome based on human microsatellite polymorphisms. Genomics 67, 237-247.
176. Shi, Q., Wang, J., Wang, X. L., and VandeBerg, J. L. (2004) Comparative analysis of vascular endothelial cell activation by TNF-alpha and LPS in humans and baboons. Cell Biochem. Biophys. 40.
177. Feng, L., Stern, D. M., and Pile-Spellman, J. (1999) Human endothelium: endovascular biopsy and molecular analysis. Radiology 212, 655-664.
178. Solovey, A. N., Gui, L., Chang, L., Enenstein, J., Browne, P. V., and Hebbel, R. P. (2001) Identification and functional assessment of endothelial P1H12. J. Lab. Clin. Med. 138, 322-331.
179. Bardin, N., Anfosso, F., Masse, J. M., Cramer, E., Sabatier, F., Le Bivic, A., et al. (2001) Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98, 3677-384.
180. Cleaver, O. and Melton, D. A. (2003) Endothelial signaling during development. Nat. Med. 9, 661-668.